one by hospitals, colleges and research companies who cannot afford access to the human genome. Genetics Professor Peter Goodfellow, Cambridge, argues that patent debate is one more of economics than ethics “If you allow…patents that cover the entire human genome, the economic consequences could be disastrous” (Watts 1). Others argue these fragments and the basic sequence of the human genome should not be owned by anyone. They argue that expensive research discoveries that arise from knowledge of the basic sequence should be afforded patent protection, but not the basic sequence itself. As President Clinton and Prime Minister Blair declared “To realize the full promise of the research, raw fundamental data on the human genome, including the human DNA sequence and its variations, should be made freely available to scientists everywhere” (You Can’t 1). Others argue the pair are frustrated because the Human Genome Project is behind the private sector in mappi
...